Carcinoma Scholarly Open Access Journals
Open Access Journal of Oncology and Medicine (OAJOM) aims to supply effective cancer therapies through the invention and development of novel therapeutics where we pine to pick a pioneering researches and practitioners with their valuable ideas and articles supported medicine (diagnosis and treatment of disease and therefore the maintenance of health) and oncology (treatments of tumors) of common, acute, long term, late effects and its recently developed treatments and welcomes research across all tumor types and their treatments in medical oncology, surgical oncology and radiation oncology
And also on two major divisions of medicine academic medicine and clinical medicine. Some of the branches of medicine are environmental medicine, family medicine, forensic medicine, internal medicine, and physical medicine. It maintains a precise, conscientious fair peer review system.
Besides, quality control is engrossed in each step of the publication is in high quality Our editorial team is committed to improving the researcher experience by providing excellent editorial service, fast publication, and high visibility for all papers.
High Impact List of Articles
-
Durable Response to Immune Checkpoint Blockade Plus Albumin-Bound Paclitaxel in Two Osimertinib-Refractory Patients with EGFR-mutated Lung Adenocarcinoma
Bo Yang, Yaping Long, Zhibo Zhang, Yuheng Ma, Zhi Cui, Pengfei Cui, Xiaoyan Li and Yi Hu Case Report: Cancer Science & Therapy
-
Durable Response to Immune Checkpoint Blockade Plus Albumin-Bound Paclitaxel in Two Osimertinib-Refractory Patients with EGFR-mutated Lung Adenocarcinoma
Bo Yang, Yaping Long, Zhibo Zhang, Yuheng Ma, Zhi Cui, Pengfei Cui, Xiaoyan Li and Yi Hu Case Report: Cancer Science & Therapy
-
Malignant Granular Cell Tumor with an Unusually Long Clinical Course: An Autopsy Case with Review of Literature
Tsuyoshi Saito, Hiroyuki Mitomi, Tomoaki Torigoe, Tatsuya Takagi, Yoshiyuki Suehara, Taketo Okubo, Kazuo Kaneko and Takashi Yao Research Article: Cancer Science & Therapy
-
Malignant Granular Cell Tumor with an Unusually Long Clinical Course: An Autopsy Case with Review of Literature
Tsuyoshi Saito, Hiroyuki Mitomi, Tomoaki Torigoe, Tatsuya Takagi, Yoshiyuki Suehara, Taketo Okubo, Kazuo Kaneko and Takashi Yao Research Article: Cancer Science & Therapy
-
Malignant Mesothelioma of Peritoneum: About a Case with Review of the Literature
Berhil H, Chenna H, Nouni K, Mouhajir N, Tolba A, Zaidi H, Mezouri V, Hassouni K, Kebdani T, El gueddari BK and Benjaafar N Case Report: Cancer Science & Therapy
-
Malignant Mesothelioma of Peritoneum: About a Case with Review of the Literature
Berhil H, Chenna H, Nouni K, Mouhajir N, Tolba A, Zaidi H, Mezouri V, Hassouni K, Kebdani T, El gueddari BK and Benjaafar N Case Report: Cancer Science & Therapy
-
Primary Mammary (Non-Hodgkin) Lymphoma of Breast: A Case Report
Akshay Nigam, Ajay Kumar Singh, Sanjeev Kumar Singh, Neelima Singh, Nivedita Singh and Anupama Sharma Case Report: Cancer Science & Therapy
-
Primary Mammary (Non-Hodgkin) Lymphoma of Breast: A Case Report
Akshay Nigam, Ajay Kumar Singh, Sanjeev Kumar Singh, Neelima Singh, Nivedita Singh and Anupama Sharma Case Report: Cancer Science & Therapy
-
Regrowth Concentration Zero (RC0) as Complementary Endpoint Parameter to Evaluate Compound Candidates During Preclinical Drug Development for Cancer Treatment
Avramidis Dimitrios, Cruz Mabel, Sidén Åke, Tasat Deborah Ruth and Yakisich J. Sebastian Research Article: Cancer Science & Therapy
-
Regrowth Concentration Zero (RC0) as Complementary Endpoint Parameter to Evaluate Compound Candidates During Preclinical Drug Development for Cancer Treatment
Avramidis Dimitrios, Cruz Mabel, Sidén Åke, Tasat Deborah Ruth and Yakisich J. Sebastian Research Article: Cancer Science & Therapy
Conference Proceedings
-
Synthesis and characterization of a {ReO}3+ complex with S- and N-donor ligands and of its 99mTc analog
N S Al-Hokbany Scientific Tracks Abstracts: Nuclear Medicine & Radiation Therapy
-
Synthesis and characterization of a {ReO}3+ complex with S- and N-donor ligands and of its 99mTc analog
N S Al-Hokbany Scientific Tracks Abstracts: Nuclear Medicine & Radiation Therapy
-
The importance of early diagnosis in patients with maxillary sinus carcinoma
Ali-Farid Safi Posters & Accepted Abstracts: Cancer Science & Therapy
-
The importance of early diagnosis in patients with maxillary sinus carcinoma
Ali-Farid Safi Posters & Accepted Abstracts: Cancer Science & Therapy
-
To delineate the histopathological pattern of prostate diseases and to highlight the agevariations, prostate specific antigen (PSA) values and histopathological features
Abdulkader Albasri, Akbar Husaini, Ibrahim Sundkji and Ahmed Ahujali Accepted Abstracts: Cancer Science & Therapy
-
To delineate the histopathological pattern of prostate diseases and to highlight the agevariations, prostate specific antigen (PSA) values and histopathological features
Abdulkader Albasri, Akbar Husaini, Ibrahim Sundkji and Ahmed Ahujali Accepted Abstracts: Cancer Science & Therapy
-
The MAGE protein family: Protein degradation, genome stability, and cancer
P. Ryan Potts Scientific Tracks Abstracts: Cancer Science & Therapy
-
The MAGE protein family: Protein degradation, genome stability, and cancer
P. Ryan Potts Scientific Tracks Abstracts: Cancer Science & Therapy
-
INCREASE IN SAFETY CULTURE FROM THE ELABORATION OF THE RISK MAP IN A CHRONIC CARE HOSPITAL
Maria Jose Merino Plaza, Amparo Martinez-Asensi, Francisco Javier Carrera-Hueso, Maria Rosa Roca-Castello, Maria Dolores Morro-Martin and Narjis
Fikri-Benbrahim Posters & Accepted Abstracts: Journal of Health & Medical Informatics
-
INCREASE IN SAFETY CULTURE FROM THE ELABORATION OF THE RISK MAP IN A CHRONIC CARE HOSPITAL
Maria Jose Merino Plaza, Amparo Martinez-Asensi, Francisco Javier Carrera-Hueso, Maria Rosa Roca-Castello, Maria Dolores Morro-Martin and Narjis
Fikri-Benbrahim Posters & Accepted Abstracts: Journal of Health & Medical Informatics
Relevant Topics in Medical Sciences
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 